Search research articles
Contact Us
Filters
Showing results (81-90 of 86) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 86 results.
Journal of Thrombosis and Haemostasis : JTH
|
February 15, 2021
Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran-Results of the phase 1 inhibitor cohort
K John Pasi, Toshko Lissitchkov, Vasily Mamonov, et al.
The New England Journal of Medicine
|
April 3, 2026
CRISPR-Cas12a Gene Editing of <i>HBG1</i> and <i>HBG2</i> Promoters to Treat Sickle Cell Disease
Rabi Hanna, Haydar Frangoul, Luis Pineiro, et al.
Journal of Medical Internet Research
|
March 20, 2026
Scalable and Robust Artificial Intelligence for Spine Alignment Assessment: Multicenter Study Enabled by Real-Time Data Transformation
Guilin Chen, Nan Meng, Yipeng Zhuang, et al.
The Lancet. Gastroenterology & Hepatology
|
April 26, 2024
Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial
Nadia Ovchinsky, Madeleine Aumar, Alastair Baker, et al.
IEEE Journal of Biomedical and Health Informatics
|
November 20, 2020
Deep Learning Methods for Lung Cancer Segmentation in Whole-Slide Histopathology Images-The ACDC@LungHP Challenge 2019
Zhang Li, Jiehua Zhang, Tao Tan, et al.
JHEP Reports : Innovation in Hepatology
|
July 17, 2023
Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis
Richard J Thompson, Reha Artan, Ulrich Baumann, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 86) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 86 results.
Journal of Thrombosis and Haemostasis : JTH
|
February 15, 2021
Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran-Results of the phase 1 inhibitor cohort
K John Pasi, Toshko Lissitchkov, Vasily Mamonov, et al.
The New England Journal of Medicine
|
April 3, 2026
CRISPR-Cas12a Gene Editing of <i>HBG1</i> and <i>HBG2</i> Promoters to Treat Sickle Cell Disease
Rabi Hanna, Haydar Frangoul, Luis Pineiro, et al.
Journal of Medical Internet Research
|
March 20, 2026
Scalable and Robust Artificial Intelligence for Spine Alignment Assessment: Multicenter Study Enabled by Real-Time Data Transformation
Guilin Chen, Nan Meng, Yipeng Zhuang, et al.
The Lancet. Gastroenterology & Hepatology
|
April 26, 2024
Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind, randomised, placebo-controlled trial
Nadia Ovchinsky, Madeleine Aumar, Alastair Baker, et al.
IEEE Journal of Biomedical and Health Informatics
|
November 20, 2020
Deep Learning Methods for Lung Cancer Segmentation in Whole-Slide Histopathology Images-The ACDC@LungHP Challenge 2019
Zhang Li, Jiehua Zhang, Tao Tan, et al.
JHEP Reports : Innovation in Hepatology
|
July 17, 2023
Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis
Richard J Thompson, Reha Artan, Ulrich Baumann, et al.
Page
of 9